Why do men go bald

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Male pattern baldness, or androgenetic alopecia, affects approximately 50% of men by age 50, with onset typically beginning in the 20s or 30s. It is primarily caused by genetic sensitivity to dihydrotestosterone (DHT), a hormone derived from testosterone, which miniaturizes hair follicles over time. While genetics account for about 80% of predisposition, factors like age, stress, and medical conditions can influence progression. Treatments like minoxidil (FDA-approved in 1988) and finasteride (approved in 1997) can slow hair loss, but there is no permanent cure.

Key Facts

Approximately 50% of men experience male pattern baldness by age 50
Genetic factors account for about 80% of predisposition to androgenetic alopecia
Dihydrotestosterone (DHT) miniaturizes hair follicles, leading to shorter growth cycles
Minoxidil was FDA-approved for hair loss treatment in 1988
Finasteride was approved for male pattern baldness in 1997

Overview

Male pattern baldness, scientifically known as androgenetic alopecia, is a common form of hair loss affecting men worldwide, with historical references dating back to ancient civilizations. Aristotle noted baldness in the 4th century BCE, while Hippocrates observed its hereditary nature. In modern times, research accelerated in the 20th century, with Dr. James B. Hamilton publishing influential studies in the 1940s linking baldness to androgens. By the 1980s, the condition was recognized as affecting millions, with prevalence increasing with age: about 25% of men show signs by age 30, rising to 50% by age 50. Cultural perceptions have varied, from symbols of wisdom in some societies to stigma in others, driving a global hair loss treatment market valued at over $10 billion annually. Key milestones include the 1992 discovery of the androgen receptor gene's role and ongoing studies on genetic markers like the AR gene on the X chromosome.

How It Works

Male pattern baldness occurs through a biological process involving hormones and genetics. It starts with the conversion of testosterone to dihydrotestosterone (DHT) by the enzyme 5-alpha-reductase in hair follicles. Genetically susceptible follicles have receptors that bind to DHT, triggering a miniaturization process: follicles shrink over time, producing thinner, shorter hairs until they stop growing entirely. This follows a predictable pattern, often beginning with a receding hairline (Norwood-Hamilton scale stage II) and thinning at the crown, progressing to more advanced stages. Hair growth cycles shorten from the usual 2-6 years to mere months, with resting phases lengthening. Factors like inflammation or oxidative stress may exacerbate this, but DHT sensitivity is central. Treatments like finasteride inhibit 5-alpha-reductase to reduce DHT levels, while minoxidil increases blood flow to follicles, though results vary individually.

Why It Matters

Understanding male pattern baldness is significant due to its widespread impact on health, psychology, and society. It affects over 50 million men in the U.S. alone, contributing to issues like reduced self-esteem and anxiety, with studies linking severe hair loss to higher rates of depression. Economically, it fuels a booming industry for treatments, transplants, and products, with hair transplant surgeries increasing by 60% from 2014 to 2021. Medically, it can signal underlying conditions like cardiovascular disease or prostate issues, as research suggests correlations with DHT levels. Socially, awareness promotes acceptance and reduces stigma, while scientific advances in genetics and hormone therapy offer insights into aging and regenerative medicine. Ultimately, addressing baldness improves quality of life and drives innovation in dermatology and biotechnology.